In silico methods and tools for drug discovery

B Shaker, S Ahmad, J Lee, C Jung, D Na - Computers in biology and …, 2021 - Elsevier
In the past, conventional drug discovery strategies have been successfully employed to
develop new drugs, but the process from lead identification to clinical trials takes more than …

A review of computational drug repositioning: strategies, approaches, opportunities, challenges, and directions

TN Jarada, JG Rokne, R Alhajj - Journal of cheminformatics, 2020 - Springer
Drug repositioning is the process of identifying novel therapeutic potentials for existing drugs
and discovering therapies for untreated diseases. Drug repositioning, therefore, plays an …

[HTML][HTML] Review of drug repositioning approaches and resources

H Xue, J Li, H Xie, Y Wang - International journal of biological …, 2018 - ncbi.nlm.nih.gov
Drug discovery is a time-consuming, high-investment, and high-risk process in traditional
drug development. Drug repositioning has become a popular strategy in recent years …

Identifying drug–target interactions based on graph convolutional network and deep neural network

T Zhao, Y Hu, LR Valsdottir, T Zang… - Briefings in …, 2021 - academic.oup.com
Identification of new drug–target interactions (DTIs) is an important but a time-consuming
and costly step in drug discovery. In recent years, to mitigate these drawbacks, researchers …

Structure and dynamics of molecular networks: a novel paradigm of drug discovery: a comprehensive review

P Csermely, T Korcsmáros, HJM Kiss, G London… - Pharmacology & …, 2013 - Elsevier
Despite considerable progress in genome-and proteome-based high-throughput screening
methods and in rational drug design, the increase in approved drugs in the past decade did …

Advancing computational toxicology in the big data era by artificial intelligence: data-driven and mechanism-driven modeling for chemical toxicity

HL Ciallella, H Zhu - Chemical research in toxicology, 2019 - ACS Publications
In 2016, the Frank R. Lautenberg Chemical Safety for the 21st Century Act became the first
US legislation to advance chemical safety evaluations by utilizing novel testing approaches …

[HTML][HTML] Open PHACTS: semantic interoperability for drug discovery

AJ Williams, L Harland, P Groth, S Pettifer… - Drug discovery today, 2012 - Elsevier
Open PHACTS is a public–private partnership between academia, publishers, small and
medium sized enterprises and pharmaceutical companies. The goal of the project is to …

Knowledge graphs and their applications in drug discovery

F MacLean - Expert opinion on drug discovery, 2021 - Taylor & Francis
Introduction Knowledge graphs have proven to be promising systems of information storage
and retrieval. Due to the recent explosion of heterogeneous multimodal data sources …

Toward interoperable bioscience data

SA Sansone, P Rocca-Serra, D Field, E Maguire… - Nature …, 2012 - nature.com
To make full use of research data, the bioscience community needs to adopt technologies
and reward mechanisms that support interoperability and promote the growth of an …

From in silico target prediction to multi-target drug design: current databases, methods and applications

A Koutsoukas, B Simms, J Kirchmair, PJ Bond… - Journal of …, 2011 - Elsevier
Given the tremendous growth of bioactivity databases, the use of computational tools to
predict protein targets of small molecules has been gaining importance in recent years …